Diabetic hypoglycaemia

Bailliere's Best Practice and Research in Clinical Endocrinology and Metabolism

Volumn 13, Issue 2, 1999, Pages 279-294

  Heller, Simon R ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Autonomic neuropathy; Cardiac electrophysiology; Hypoglycaemia; Hypoglycaemia unawareness; Sudden death; Type 1 diabetes

Indexed keywords

ADRENALIN; GLUCAGON; GLUCOSE; INSULIN; SULFONYLUREA;

AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE MONITORING; COGNITIVE DEFECT; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; GLUCOSE BLOOD LEVEL; GLUCOSE BRAIN LEVEL; GLUCOSE TRANSPORT; HUMAN; HYPOGLYCEMIA; MONITOR; PATIENT EDUCATION; REVIEW; SYMPTOM;

EID: 0033508725     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1053/beem.1999.0020     Document Type: Article

References (86)

1. Ollson P O, Arnqvist H J, von Schenk H. Free insulin profiles in insulin dependent diabetics treated with one or two insulin injections per day. Acta Medica Scandinavica. 220:1986;133-141.
2. Schwartz N S, Clutter W E, Shah S D. The glycemic thresholds for the activation of glucose counterregulation are higher than the threshold for symptoms. Journal of Clinical Investigation. 79:1987;777-781.
3. Blundell T, Dodson G, Hodgkin D. Insulin: the structure in crystal and its reflection in chemistry and biology. Advances in Protein Chemistry. 26:1972;279-402.
4. Barnett A H, Owens D R. Insulin analogues. Lancet. 349:1997;47-51.
5. Brunelle R L, Llewelyn J, Anderson J H. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care. 21:1998;1726-1731.
6. Frier B M. Hypoglycaemia in the diabetic adult. Baillière's Clinical Endocrinology and Metabolism. 7:1993;757-777.
7. Tattersall R B. Frequency and causes of hypoglycaemia. Frier B M, Fisher B M. Hypoglycaemia and Diabetes. Clinical and Physiological Aspects. 1993;176-189 Edward Arnold, London.
8. Diabetes Care. 18:1995;1415-1427.
9. Pramming S, Thorsteinsson B, Bendtson I. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabetic Medicine. 8:1991;217-222.
10. Lancet. 352:1998;837-853.
11. Heller S R. Hypoglycaemia and type 2 diabetes: insulin therapy. Frier B M, Fisher B M. Hypoglycaemia and Diabetes. Clinical and Physiological Aspects. 1993;393-400 Edward Arnold, London.
12. Mühlhauser I, Overmann H, Bender R. Risk factors of severe hypoglycaemia in adult patients with Type 1 diabetes - a prospective population based study. Diabetologia. 41:1998;1274-1282.
13. Bott S, Bott U, Berger M. Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia. 40:1997;926-932.
14. Pampanelli S, Fanelli C, Lalli C. Long-term intensive insulin therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia. Diabetologia. 39:1996;677-686.
15. Heller S R, Cryer P E. Hypoinsulinemia is not critical to glucose recovery from hypoglycemia in humans. American Journal of Physiology. 261:1991;E41-E48.
16. Rizza R A, Cryer P E, Gerich J E. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. Journal of Clinical Investigation. 64:1979;62-71.
17. Cryer P E. Hypoglycemia: the limiting factor in the management of IDDM. Diabetes. 43:1994;1378-1389.
18. Deary I J, Hepburn D A, MacLeod K M. Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis. Diabetologia. 36:1993;771-777.
19. McCrimmon R J, Gold A E, Deary I J. Symptoms of hypoglycemia in children with IDDM. Diabetes Care. 18:1995;858-861.
20. Jaap A J, Jones G C, McCrimmon R J. Perceived symptoms of hypoglycaemia in elderly type 2 diabetic patients treated with insulin. Diabetic Medicine. 15:1998;398-401.
21. Heller S R, Macdonald I A, Herbert M. Influence of sympathetic nervous system on hypoglycaemic warning symptoms. Lancet. ii:1987;359-363.
22. Mitrakou A, Ryan C M, Veneman T. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms and cerebral dysfunction. American Journal of Physiology. 260:1991;E67-E74.
23. Bolli G B, De Feo P, Compagnucci P. Abnormal glucose counterregulation in IDDM. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes. 32:1983;134-141.
24. Gerich J E, Langlois M, Noacco C. Lack of glucagon response to hypoglycaemia in diabetes; evidence for an intrinsic pancreatic alpha cell defect. Science. 182:1973;171-173.
25. Taborsky G J Jr, Ahren B, Havel P J. Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired alpha-cell responses in type 1 diabetes. Diabetes. 47:1998;995-1005.
26. Hirsch B R, Shamoon H. Defective epinephrine and growth hormone responses in type 1 diabetes are stimulus specific. Diabetes. 36:1987;20-26.
27. Gerich J E, Bolli G B. Counterregulatory failure. Fisher B M, Frier B M. Hypoglycaemia and Diabetes. Clinical and Physiological Aspects. 1993;253-267 Edward Arnold, London.
28. White N H, Skor D A, Cryer P E. Identificaiton of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. New England Journal of Medicine. 308:1983;485-491.
29. Fritsche A, Stumvoll M, Grub M. Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects. Diabetes Care. 21:1998;1505-1510.
30. Hepburn D A, Patrick A W, Eadington D W. Unawareness of hypoglycaemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy. Diabetic Medicine. 7:1990;711-717.
31. Mühlhauser I, Berger M, Sonnenberg G E. Incidence and management of severe hypoglycemia in 434 adults with insulin-dependent diabetes mellitus. Diabetes Care. 8:1985;268-273.
32. Gold A E, MacLeod K M, Frier B M. Frequency of severe hypoglycemia in patients with type I (insulin dependent) diabetes with impaired awareness of hypoglycemia. Diabetes Care. 17:1994;697-703.
33. Hoeldtke R D, Boden G, Shuman C R. Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. Annals of Internal Medicine. 96:1982;459-462.
34. Ryder R EJ, Owens D R, Hayes T M. Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy. British Medical Journal. 301:1990;783-787.
35. Hepburn D A, MacLeod K M, Frier B M. Physiological, symptomatic and hormonal responses to acute hypoglycaemia in type 1 diabetic patients with autonomic neuropathy. Diabetic Medicine. 10:1993;940-949.
36. Bottini P, Boschetti E, Pampanelli S. Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycaemia in IDDM. Diabetes. 46:1997;814-823.
37. Amiel S A, Sherwin R S, Simonson D C. Effect of intensive insulin therapy on glycemic threshold for counterregulatory hormone release. Diabetes. 37:1988;901-907.
38. Goldfien A, Moore R, Zileli S. Plasma epinephrine and norepinephrine levels during insulin-induced hypoglycaemia in man. Journal of Clinical Endocrinology and Metabolism. 21:1961;296-303.
39. Heller S R, Cryer P E. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after one episode of hypoglycemia in non-diabetic humans. Diabetes. 40:1991;223-226.
40. Widom B, Simonson D C. Intermittent hypoglycemia impairs glucose counterregulation. Diabetes. 41:1992;1597-1602.
41. Dagogo-Jack S E, Craft S, Cryer P E. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Journal of Clinical Investigation. 91:1993;819-828.
42. George E, Harris N, Bedford C. Prolonged but partial impairment of the hypoglycaemic physiological response following short-term hypoglycaemia in normal subjects. Diabetologia. 38:1995;1183-1190.
43. George E, Marques J L, Harris N D. Preservation of physiological responses to hypoglycemia 2 days after antecedent hypoglycemia in patients with IDDM. Diabetes Care. 20:1997;1293-1298.
44. Cryer P E. Hypoglycemia unawareness in IDDM. Diabetes Care. 16:1994;40-47.
45. Hepburn D A, Partick A W, Brash H M. Hypoglycaemia unawareness in type 1 diabetes: a lower plasma glucose is required to stimulate sympathoadrenal activation. Diabetic Medicine. 8:1991;934-945.
46. Heller S R, Macdonald I A. The measurement of cognitive function during acute hypoglycaemia: experimental limitations and their effect on the study of hypoglycaemia unawareness. Diabetic Medicine. 13:1996;607-615.
47. Amiel S A. Cognitive function testing in studies of acute hypoglycaemia: rights and wrongs? Diabetologia. 41:1998;713-719.
48. McCall A L, Fixman L B, Fleming N. Chronic hypoglycemia increases brain glucose transport. American Journal of Physiology. 251:1986;E442-E447.
49. Kumagai A K, Kang Y-S, Boado R J. Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycaemia. Diabetes. 44:1995;1399-1404.
50. Boyle P J, Nagy R J, O'Connor A M. Adaptation in brian glucose uptake following recurrent hypoglycemia. Proceedings of the National Academy of Sciences of the USA. 1994;9352-9356.
51. Boyle P J, Kempers S F, O'Connor A M. Brain glucose uptake and unawareness of hypoglycaemia in patients with insulin-dependent diabetes mellitus. New England Journal of Medicine. 28:1995;1726-1731.
52. Borg M A, Borg W P, Tamborlane W V. Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats. Diabetes. 48:1999;584-587.
53. Fanelli C G, Paramore D S, Hershey T. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes. 47:1998;1920-1927.
54. Fanelli C G, Pampanelli S, Porcellati F. Shift of glycaemic thresholds for cognitive function in hypoglycaemia unawareness in humans. Diabetologia. 41:1998;720-723.
55. Davis S N, Shavers C, Costa F. Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. Journal of Clinical Investigation. 98:1996;680-691.
56. Davis S N, Shavers C, Davis B. Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses. Journal of Clinical Investigation. 100:1997;429-438.
57. Fanelli C G, Epifano L, Rambotti A M. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes. 42:1993;1683-1689.
58. Cranston I, Lomas J, Maran A. Restoration of hypoglycaemia unawareness in patients with long-duration insulin-dependent diabetes. Lancet. 344:1994;283-287.
59. Dagogo-Jack S E, Rattarasarn C, Cryer P E. Reversal of hypoglycemia unawareness, but not counterregulation, in IDDM. Diabetes. 43:1994;1426-1434.
60. Debrah K, Sherwin R S, Murphy J. Effect of caffeine on recognition of and physiological responses to hypoglycaemia in insulin-dependent diabetes. Lancet. 347:1996;19-24.
61. Tattersall R B, Gill G V. Unexplained deaths of type 1 diabetic patients. Diabetic Medicine. 8:1991;49-58.
62. Campbell I W. Dead in bed syndrome: a new manifestation of nocturnal hypoglycaemia? Diabetic Medicine. 8:1991;3-4.
63. Borch-Johnsen K, Helweg-Larsen K. Sudden death and human insulin: is there a link? Diabetic Medicine. 10:1993;255-259.
64. Thordarson H, Sovik O. Dead in bed syndrome in young diabetic patients in Norway. Diabetic Medicine. 12:1995;782-787.
65. Sartor G, Dahlquist G. Short-term mortality in childhood onset insulin-dependent diabetes mellitus: a high frequency of unexpected deaths in bed. Diabetic Medicine. 12:1995;607-611.
66. Collier A, Matthews D M, Young R J. Transient atrial fibrillation precipitated by hypoglycaemia: 2 case reports. Postgraduate Medical Journal. 63:1987;895-897.
67. Lindstrom T, Jorfeldt L, Tegler L. Hypoglycaemia and cardiac arrhythmias in patients with Type 2 diabetes. Diabetic Medicine. 9:1992;536-541.
68. Shimada R, Nakashima T, Nunoi K. Arrhythmia during insulin-induced hypoglycemia in a diabetic patient. Archives of Internal Medicine. 144:1984;1068-1069.
69. Markel A, Keidar S, Yasin K. Hypoglycaemia-induced ischaemic ECG changes. Presse Medicale. 23:1994;78-79.
70. Jervell A, Lange-Neilsen F. Congenital deaf-mutism; functional heart disease with prolongation of the QT interval and sudden death. American Heart Journal. 54:1957;59-68.
71. Curran M E, Splawski I, Timothy K W. A molecular basis for cardiac arrhythmias: HERG mutations cause long QT syndrome. Cell. 80:1995;795-803.
72. Lloyd-Mostyn R H, Oram S. Modification by propranolol of cardiovascular effects of induced hypoglycaemia. Lancet. i:1975;1213-1215.
73. DiSalvo R J, Bloom W L, Brust A A. A comparison of the metabolic and circulatory effects of epinephrine, norepinephrine and insulin hypoglycemia with observations on the influence of autonomic blocking agents. Journal of Clinical Investigation. 35:1956;568-577.
74. Marques J L, George E, Peacey S R. Altered ventricular repolarization during hypoglycaemia in patients with diabetes. Diabetic Medicine. 14:1997;648-654.
75. Marques J LB, George E, Cochrane T. QTc interval prolongation during hypoglycaemia: a possible mechanism of sudden death. Diabetic Medicine. 12:1995;S9.
76. Malpas S C, Maling T J. Heart rate variability and cardiac autonomic function in diabetes. Diabetes. 39:1990;1171-1181.
77. Weston P J, Panerai R B, McCullough A. Assessment of baroceptor-cardiac reflex sensitivity using time domain analysis in patients with IDDM. Diabetologia. 39:1996;1385-1391.
78. Pagani M, Lombardi F, Guzzetti S. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circulation Research. 59:1986;178-193.
79. Weston P J, James M A, Panerai R. Abnormal baroreceptor-cardiac reflex sensitivity is not detected by conventional tests of autonomic function in patients with insulin-dependent diabetes mellitus. Clinical Science. 91:1996;59-64.
80. Weston P J, Gill G V. Is undetected autonomic dysfunction responsible for sudden death in Type 1 diabetes mellitus? 'Dead in bed' syndrome revisited. Diabetic Medicine. 16:1999;626-631.
81. Deary I J, Crawford J R, Hepburn D A. Severe hypoglycaemia and intelligence in adult patients with insulin-treated diabetes. Diabetes. 42:1993;341-344.
82. Langan S J, Deary I J, Hepburn D A. Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia. 34:1991;337-344.
83. Ryan C M, Williams T M, Finegold D N. Cognitive dysfunction in adults with type 1 (insulin-dependent) diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications. Diabetologia. 36:1993;329-334.
84. Reichard P, Pihl M. Mortality and treatment side effects during long term intensive conventional insulin treatment in the Stockholm Diabetes Intervention Study. Diabetes. 43:1994;313-317.
85. Annals of Internal Medicine. 124:1996;379-388.
86. Deary I J, Frier B M. Severe hypoglycaemia and cognitive impairment in diabetes. British Medical Journal. 313:1996;767-768.